series-b
Stage
2016
Founded
1
Investors
About
Gesynta Pharma is a clinical-stage pharmaceutical company developing novel treatments for microvascular diseases. Their lead candidate, GS-248, targets microvascular angina.
Explore Gesynta Pharma AB's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.